Market Cap 2.28B
Revenue (ttm) 0.00
Net Income (ttm) -299.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.18
Volume 1,033,500
Avg Vol 2,150,982
Day's Range N/A - N/A
Shares Out 72.06M
Stochastic %K 81%
Beta 0.92
Analysts Strong Sell
Price Target $78.00

Company Profile

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 770 0077
Website: veratx.com
Address:
2000 Sierra Point Parkway, Suite 1200, Brisbane, United States
N0_Brainers
N0_Brainers Aug. 18 at 7:01 PM
$VERA $35 calls unusual volume - September
1 · Reply
greensmell
greensmell Aug. 18 at 2:13 PM
$VERA This stock is a nightmare
2 · Reply
CH_Expat
CH_Expat Aug. 18 at 6:02 AM
$IDYA $MLYS $VERA Those three stocks underperformed XBI by more than 50% YTD. Interesting.
4 · Reply
grandefappuccino
grandefappuccino Aug. 17 at 8:22 PM
$VERA Vera’s newly approved IgA nephropathy drug supports kidney function https://www.biospace.com/drug-development/veras-newly-approved-iga-nephropathy-drug-supports-kidney-function-like-otsukas-voyxact
0 · Reply
zackopaw
zackopaw Aug. 17 at 11:27 AM
$VERA we do have Pioneer results also expected in Q4 2026.. something to remember
0 · Reply
CH_Expat
CH_Expat Aug. 17 at 7:45 AM
$VERA $IDYA $MLYS Always encouraging to see in the 13Fs that the biotech All-Star-Funds bought more of your holdings for higher prices than you did. Not the one parameter to watch, but gives you a good feeling anyway.
1 · Reply
biochirp
biochirp Aug. 16 at 12:46 AM
$VERA algos fought hard but there’s real buying happening, next month should be good
0 · Reply
flamingojack
flamingojack Aug. 15 at 6:21 PM
$VERA i just read this amazing post on X, which demonstrates how a lot of the eGFR data is already out and the bear case was a timing opportunity but it’s now cooked (explains why) and things are looking up for the bulls. https://x.com/seedy19tron/status/2088224728691446125?s=46 Another good post by another analyst: https://x.com/semodough/status/2088283508217188725?s=46 Yes, you saw that correctly. Goldman Sachs has given $VERA an M&A rank of 1. (Scale 1-3, 1 highest probability) Lets 🚀 f’n 🚀 GOOOO
0 · Reply
biochirp
biochirp Aug. 15 at 12:14 AM
$VERA liking the next 3 months on this
0 · Reply
flamingojack
flamingojack Aug. 14 at 4:27 PM
0 · Reply
Latest News on VERA
Vera Therapeutics reports Q3 EPS ($1.52), consensus ($1.59)

2026-08-10T21:05:19.000Z - 8 days ago

Vera Therapeutics reports Q3 EPS ($1.52), consensus ($1.59)


Vera Therapeutics Earnings release: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 8 days ago

Vera Therapeutics Earnings release: Q2 2026


Vera Therapeutics Quarterly report: Q2 2026

Aug 10, 2026, 4:00 PM EDT - 8 days ago

Vera Therapeutics Quarterly report: Q2 2026


Vera Therapeutics Transcript: FDA announcement

Jul 7, 2026, 4:30 PM EDT - 6 weeks ago

Vera Therapeutics Transcript: FDA announcement


Vera Therapeutics Press release: FDA announcement

Jul 7, 2026, 4:30 PM EDT - 6 weeks ago

Vera Therapeutics Press release: FDA announcement


Vera Therapeutics price target raised to $70 from $65 at BofA

2026-07-07T18:10:10.000Z - 6 weeks ago

Vera Therapeutics price target raised to $70 from $65 at BofA


US FDA approves Vera's kidney disease drug

Jul 7, 2026, 12:42 PM EDT - 6 weeks ago

US FDA approves Vera's kidney disease drug


Vera Therapeutics Slides: Corporate presentation

Jul 7, 2026, 7:00 AM EDT - 6 weeks ago

Vera Therapeutics Slides: Corporate presentation


Vera Therapeutics Transcript: AGM 2026

May 21, 2026, 11:00 AM EDT - 3 months ago

Vera Therapeutics Transcript: AGM 2026


Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37)

2026-05-07T20:08:52.000Z - 3 months ago

Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37)


Vera Therapeutics Earnings release: Q1 2026

May 7, 2026, 7:30 AM EDT - 3 months ago

Vera Therapeutics Earnings release: Q1 2026


Vera Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:30 AM EDT - 3 months ago

Vera Therapeutics Quarterly report: Q1 2026


Vera Therapeutics Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Vera Therapeutics Proxy statement: Proxy filing


Vera Therapeutics Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Vera Therapeutics Proxy statement: Proxy filing


Vera Therapeutics appoints Hite to Board of Directors

2026-03-05T14:16:31.000Z - 5 months ago

Vera Therapeutics appoints Hite to Board of Directors


Vera Therapeutics Annual report: Q4 2025

Feb 26, 2026, 7:30 AM EST - 6 months ago

Vera Therapeutics Annual report: Q4 2025


Vera Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 7:30 AM EST - 6 months ago

Vera Therapeutics Earnings release: Q4 2025


Vera Therapeutics Slides: Corporate presentation

Jan 28, 2026, 7:00 AM EST - 7 months ago

Vera Therapeutics Slides: Corporate presentation


Vera Therapeutics Slides: Corporate presentation

Jan 9, 2026, 7:00 AM EST - 7 months ago

Vera Therapeutics Slides: Corporate presentation


Vera Therapeutics Transcript: KOL Event

Nov 6, 2025, 4:30 PM EST - 10 months ago

Vera Therapeutics Transcript: KOL Event


Vera Therapeutics Press release: KOL Event

Nov 6, 2025, 4:30 PM EST - 10 months ago

Vera Therapeutics Press release: KOL Event


Vera Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 4:30 PM EST - 10 months ago

Vera Therapeutics Slides: Corporate Presentation


Vera Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

Vera Therapeutics Earnings release: Q3 2025


Vera Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

Vera Therapeutics Quarterly report: Q3 2025


Vera Therapeutics Quarterly report: Q2 2025

Aug 5, 2025, 12:30 PM EDT - 1 year ago

Vera Therapeutics Quarterly report: Q2 2025


Vera Therapeutics Earnings release: Q2 2025

Aug 5, 2025, 12:30 PM EDT - 1 year ago

Vera Therapeutics Earnings release: Q2 2025


Vera Therapeutics Transcript: Study Result

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Vera Therapeutics Transcript: Study Result


Vera Therapeutics Press release: Study Result

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Vera Therapeutics Press release: Study Result


Vera Therapeutics Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Vera Therapeutics Quarterly report: Q1 2025


Vera Therapeutics Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Vera Therapeutics Earnings release: Q1 2025


Vera Therapeutics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vera Therapeutics Proxy statement: Proxy Filing


Vera Therapeutics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vera Therapeutics Proxy statement: Proxy Filing


Vera Therapeutics Annual report: Q4 2024

Feb 26, 2025, 8:00 AM EST - 1 year ago

Vera Therapeutics Annual report: Q4 2024


Vera Therapeutics Earnings release: Q4 2024

Feb 26, 2025, 8:00 AM EST - 1 year ago

Vera Therapeutics Earnings release: Q4 2024


Vera Therapeutics Slides: FY 2025

Jan 13, 2025, 7:30 PM EST - 1 year ago

Vera Therapeutics Slides: FY 2025


Vera Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Vera Therapeutics Quarterly report: Q3 2024


Vera Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Vera Therapeutics Earnings release: Q3 2024


Vera Therapeutics Transcript: Study Result

Oct 28, 2024, 8:00 AM EDT - 1 year ago

Vera Therapeutics Transcript: Study Result


Vera Therapeutics Slides: Study Result

Oct 28, 2024, 8:00 AM EDT - 1 year ago

Vera Therapeutics Slides: Study Result


Vera Therapeutics Transcript: R&D Day 2024

Oct 2, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Transcript: R&D Day 2024


Vera Therapeutics Slides: FY 2024

Oct 2, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Slides: FY 2024


Vera Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Quarterly report: Q2 2024


Vera Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Earnings release: Q2 2024


Vera Therapeutics Slides: Corporate Presentation

Jun 3, 2024, 7:00 AM EDT - 2 years ago

Vera Therapeutics Slides: Corporate Presentation


Vera Therapeutics Quarterly report: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

Vera Therapeutics Quarterly report: Q1 2024


Vera Therapeutics Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

Vera Therapeutics Earnings release: Q1 2024


Vera Therapeutics Proxy statement: Proxy Filing

May 3, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Proxy statement: Proxy Filing


Vera Therapeutics Proxy statement: Proxy Filing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Proxy statement: Proxy Filing


Vera Therapeutics Proxy statement: Proxy Filing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Proxy statement: Proxy Filing


Vera Therapeutics Annual report: Q4 2023

Mar 20, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Annual report: Q4 2023


Vera Therapeutics Earnings release: Q4 2023

Mar 20, 2024, 8:00 AM EDT - 2 years ago

Vera Therapeutics Earnings release: Q4 2023


Vera Therapeutics Slides: Corporate Presentation

Feb 14, 2024, 2:00 AM EST - 2 years ago

Vera Therapeutics Slides: Corporate Presentation


Vera Therapeutics Transcript: R&D Day 2024

Jan 25, 2024, 8:00 AM EST - 2 years ago

Vera Therapeutics Transcript: R&D Day 2024


Vera Therapeutics Press release: FY 2024

Jan 25, 2024, 8:00 AM EST - 2 years ago

Vera Therapeutics Press release: FY 2024


Vera Therapeutics Slides: FY 2024

Jan 25, 2024, 8:00 AM EST - 2 years ago

Vera Therapeutics Slides: FY 2024


N0_Brainers
N0_Brainers Aug. 18 at 7:01 PM
$VERA $35 calls unusual volume - September
1 · Reply
greensmell
greensmell Aug. 18 at 2:13 PM
$VERA This stock is a nightmare
2 · Reply
CH_Expat
CH_Expat Aug. 18 at 6:02 AM
$IDYA $MLYS $VERA Those three stocks underperformed XBI by more than 50% YTD. Interesting.
4 · Reply
grandefappuccino
grandefappuccino Aug. 17 at 8:22 PM
$VERA Vera’s newly approved IgA nephropathy drug supports kidney function https://www.biospace.com/drug-development/veras-newly-approved-iga-nephropathy-drug-supports-kidney-function-like-otsukas-voyxact
0 · Reply
zackopaw
zackopaw Aug. 17 at 11:27 AM
$VERA we do have Pioneer results also expected in Q4 2026.. something to remember
0 · Reply
CH_Expat
CH_Expat Aug. 17 at 7:45 AM
$VERA $IDYA $MLYS Always encouraging to see in the 13Fs that the biotech All-Star-Funds bought more of your holdings for higher prices than you did. Not the one parameter to watch, but gives you a good feeling anyway.
1 · Reply
biochirp
biochirp Aug. 16 at 12:46 AM
$VERA algos fought hard but there’s real buying happening, next month should be good
0 · Reply
flamingojack
flamingojack Aug. 15 at 6:21 PM
$VERA i just read this amazing post on X, which demonstrates how a lot of the eGFR data is already out and the bear case was a timing opportunity but it’s now cooked (explains why) and things are looking up for the bulls. https://x.com/seedy19tron/status/2088224728691446125?s=46 Another good post by another analyst: https://x.com/semodough/status/2088283508217188725?s=46 Yes, you saw that correctly. Goldman Sachs has given $VERA an M&A rank of 1. (Scale 1-3, 1 highest probability) Lets 🚀 f’n 🚀 GOOOO
0 · Reply
biochirp
biochirp Aug. 15 at 12:14 AM
$VERA liking the next 3 months on this
0 · Reply
flamingojack
flamingojack Aug. 14 at 4:27 PM
0 · Reply
OnlyFibs
OnlyFibs Aug. 14 at 3:55 PM
$VERA UNUSUAL OPTIONS ACTIVITY DETECTED
0 · Reply
biochirp
biochirp Aug. 14 at 2:26 PM
$VERA algos fighting to keep this down
1 · Reply
RazorbackAJ
RazorbackAJ Aug. 14 at 2:13 PM
$VERA Up 15%+ from this short and current trailing stop at $33 and in mega profits. Follow so you don't miss the next one — exact entry, exact stop, no fluff.
2 · Reply
CH_Expat
CH_Expat Aug. 14 at 2:09 PM
$VERA Might be adding on green to red. They want to make retail feel everything is priced in. I noticed this pattern in many quality bios. I like this setups, you can make good money out of it.
0 · Reply
h00man89
h00man89 Aug. 14 at 1:58 PM
$VERA $85 target price.. 150% upside with news coming.. I'm in
0 · Reply
Oscarca
Oscarca Aug. 14 at 1:50 PM
$VERA need that UNO reverse card going north again ⬆️
1 · Reply
notreload_ai
notreload_ai Aug. 14 at 12:57 PM
FDA review papers reveal encouraging Week 52 eGFR findings (+5.2 placebo-adjusted) for $VERA TRUTAKNA in primary IgA nephropathy patients. https://notreload.xyz/xy/fda-review-of-vera-trutakna-reveals-promising-egfr-data/
0 · Reply
EBE_day
EBE_day Aug. 14 at 12:42 PM
$VERA now that approval is in. We should expect commercialization news any day. This er released is showing they have enough cash for this stage and appointment of experienced regulatory officer.
0 · Reply
MiyagisenseiJr
MiyagisenseiJr Aug. 14 at 12:29 PM
$VERA losing steam already....
0 · Reply
flamingojack
flamingojack Aug. 14 at 11:59 AM
$VERA my guess: 1) big chunk of shorts covering or 2) BO. Maybe both if we’re lucky.
1 · Reply
RazorbackAJ
RazorbackAJ Aug. 14 at 11:56 AM
$VERA Shorting this nonsense move right here with current trailing stop above $38. Manage your size. Follow for setups like this — exact entries, precise stop levels, nothing vague. This is how I trade, not financial advice.
1 · Reply
chrssyngrg978
chrssyngrg978 Aug. 14 at 11:51 AM
$VERA halted??
1 · Reply